Insider Transactions in Q2 2025 at Ardelyx, Inc. (ARDX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 20
2025
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,421
-1.57%
|
$25,684
$4.08 P/Share
|
|
May 20
2025
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
5,992
-1.89%
|
$23,968
$4.08 P/Share
|
|
May 20
2025
|
Mike Kelliher Officer |
SELL
Open market or private sale
|
Direct |
14,522
-4.89%
|
$58,088
$4.08 P/Share
|
|
May 20
2025
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
46,817
-2.94%
|
$187,268
$4.08 P/Share
|
|
May 20
2025
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,218
-1.71%
|
$28,872
$4.08 P/Share
|
|
May 20
2025
|
Eric Duane Foster Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,507
-0.79%
|
$10,028
$4.08 P/Share
|
|
May 15
2025
|
David M Mott Director |
BUY
Open market or private purchase
|
Direct |
100,000
+3.85%
|
$300,000
$3.29 P/Share
|
|
May 02
2025
|
David M Mott Director |
BUY
Open market or private purchase
|
Direct |
381,377
+13.73%
|
$1,525,508
$4.22 P/Share
|
|
May 02
2025
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
41,666
-2.55%
|
$166,664
$4.25 P/Share
|
|
May 02
2025
|
Michael Raab President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,833
+1.26%
|
$0
$0.99 P/Share
|
|
Apr 28
2025
|
Merdad Parsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,056
+50.0%
|
-
|
|
Apr 04
2025
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
41,666
-2.51%
|
$166,664
$4.59 P/Share
|
|
Apr 04
2025
|
Michael Raab President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,833
+1.24%
|
$0
$0.99 P/Share
|